Matt Herper is currently a senior editor at Forbes Magazine. He has covered science and medicine from the Human Genome Project through Vioxx to the blossoming DNA technology changing the world today. He consistently covers the biotechnology and pharmaceutical industry and is one of the most prominent journalists in this space. Herper received his bachelor of science from the Massachusetts Institute of Technology and his master of science in journalism from Columbia University.
[Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.]